Propofol + Remifentanil vs. Propofol + Dexmedetomidine in Adolescent Idiopathic Scoliosis Patients Having Spine Surgery
A Prospective Study Comparing Total Intravenous Anesthesia With Propofol and Remifentanil vs. Propofol and Dexmedetomidine in Adolescent Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion and Instrumentation
Sponsor: Cedars-Sinai Medical Center
Terminated
The primary surgeon decided to prematurely halt the study because he anecdotally felt that one of the trial drugs (Dexmedetomidine) could affect the motor evoked potential monitoring necessary for the surgery.
Other terminated trials from Cedars-Sinai Medical Center
Other Adolescent Idiopathic Scoliosis trials with similar outcome
A PHASE2 clinical study on Adolescent Idiopathic Scoliosis and Dexmedetomidine, this trial is terminated or withdrawn. The trial is conducted by Cedars-Sinai Medical Center and has accumulated 4 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Dec 2025 — Present [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Sep 2024 — Dec 2025 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE2
-
Nov 2023 — Jul 2024 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cedars-Sinai Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .